Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Teladoc ( (TDOC) ) just unveiled an update.
On December 9, 2025, Teladoc Health, Inc. amended its 2023 Employment Inducement Incentive Award Plan to increase the number of shares reserved for issuance by 1,780,000, bringing the total to 7,280,000 shares. This amendment, made without stockholder approval per NYSE Rule 303A.08, reflects the company’s strategic move to enhance its stock-based incentive offerings, potentially impacting its employee retention and attraction strategies.
The most recent analyst rating on (TDOC) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Teladoc stock, see the TDOC Stock Forecast page.
Spark’s Take on TDOC Stock
According to Spark, TipRanks’ AI Analyst, TDOC is a Neutral.
Teladoc’s overall stock score reflects significant financial and technical challenges. The company’s persistent losses and negative valuation metrics weigh heavily on the score. While the earnings call provided some positive insights, such as exceeding revenue guidance and international growth, these are overshadowed by the bearish technical indicators and ongoing operational inefficiencies.
To see Spark’s full report on TDOC stock, click here.
More about Teladoc
Teladoc Health, Inc. operates in the telehealth industry, providing virtual healthcare services and solutions. The company focuses on offering remote medical consultations and healthcare management, catering to a wide range of patient needs.
Average Trading Volume: 7,542,460
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.36B
For an in-depth examination of TDOC stock, go to TipRanks’ Overview page.